Testing effectiveness (Phase 2)Looking for participantsNCT06599658
What this trial is testing
COVID-19 Booster and IIV Schedule in Immunocompromised Hosts
Who this might be right for
COVID 19InfluenzaRheumatoid Arthritis (RA)+5 more
McGill University Health Centre/Research Institute of the McGill University Health Centre 660